Anke Kretz-Rommel
Direttore Tecnico/Scientifico/R&S presso Bird Rock Bio, Inc.
Profilo
Anke Kretz-Rommel is currently the Chief Technology Officer at Bird Rock Bio, Inc. Previously, she worked as a Principal at Alexion Antibody Technologies.
She holds a doctorate degree from the Swiss Federal Institute of Technology.
Posizioni attive di Anke Kretz-Rommel
| Società | Posizione | Inizio |
|---|---|---|
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Direttore Tecnico/Scientifico/R&S | 27/08/2009 |
Precedenti posizioni note di Anke Kretz-Rommel
| Società | Posizione | Fine |
|---|---|---|
Alexion Antibody Technologies
 Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases. | Corporate Officer/Principal | - |
Formazione di Anke Kretz-Rommel
| Swiss Federal Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Health Technology |
Alexion Antibody Technologies
Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases. | Commercial Services |
- Borsa valori
- Insiders
- Anke Kretz-Rommel
